Pharma Industry News Weekly Recap: December 2, 2022

2022-12-02T11:46:46-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics AstraZeneca beefs up COPD pipeline with $400M biobuck bet on C4X program November 28, [...]

Pharma Industry News Weekly Recap: November 18, 2022

2022-11-18T10:59:39-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Adamis, Harpoon, Neoleukin and Tricida add to biotech layoff wave as pipeline setbacks [...]

Pharma Industry News Weekly Recap: November 11, 2022

2022-11-11T09:25:35-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Early data hint at benefit for Amgen’s obesity drug November 8, 2022 / [...]

Pharma Industry News Weekly Recap: October 28, 2022

2022-10-28T11:22:33-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, Diabetes, Digital Health, Drug Discovery, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics J&J wins approval of new kind of multiple myeloma drug October 26, 2022 [...]

Pharma Industry News Weekly Recap: October 21, 2022

2022-10-21T09:47:23-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, Diabetes, Digital Health, Drug Discovery, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics PIC Closes $35M Series A to Advance Novel Breast Cancer Therapeutic October 19, [...]

Pharma Industry News Weekly Recap: October 13, 2022

2022-10-14T08:21:12-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, Diabetes, Digital Health, Drug Discovery, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics October 10, 2022 / RNA / Startup / Chronic Liver Disease -Ochre Bio [...]

Pharma Industry News Weekly Recap: October 7, 2022

2022-10-07T14:00:14-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Mergers, Obesity, Oncology, Opioids, Politics, San Diego Biotech, Women's Health|

// Biotech and Pharma Therapeutics Lilly's tirzepatide slides into FDA fast lane for obesity, turning up heat on Novo [...]

Pharma Industry News Weekly Recap: September 30, 2022

2022-09-30T09:48:26-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Heart Failure, Industry News, Insulin, Mergers, Obesity, Oncology, Opioids, Politics, San Diego Biotech, Women's Health|

// Biotech and Pharma Therapeutics Eisai and Biogen's phase 3 Alzheimer's win puts amyloid back in the driver's seat, [...]

Go to Top